Aorta and Peripheral Artery Diseases

Slobodin G, Naschitz JE, Zuckerman E, Zisman D, Rozenbaum M, Boulman N, Rosner I. Aortic involvement in rheumatic diseases. Clin Exp Rheumatol. 2006;24(2 Suppl 41):S41-7.

Zoubi T, Gordon H. Systematic review of associations between concomitant rheumatoid arthritis and peripheral arterial disease, health-related quality of life and functional capacity. Rheumatol Int. 2023;43(2):221-32.

Botts SR, Fish JE, Howe KL. Dysfunctional Vascular Endothelium as a Driver of Atherosclerosis: Emerging Insights Into Pathogenesis and Treatment. Front Pharmacol. 2021;12:787541.

Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135-43.

Tabas I, Bornfeldt KE. Macrophage Phenotype and Function in Different Stages of Atherosclerosis. Circ Res. 2016;118(4):653-67.

Miller YI, Viriyakosol S, Binder CJ, Feramisco JR, Kirkland TN, Witztum JL. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem. 2003;278(3):1561-8.

Chen J, Xiang X, Nie L, Guo X, Zhang F, Wen C, et al. The emerging role of Th1 cells in atherosclerosis and its implications for therapy. Front Immunol. 2022;13:1079668.

Taleb S, Tedgui A, Mallat Z. IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles. Arterioscler Thromb Vasc Biol. 2015;35(2):258-64.

KyawT T, HosseiniH, KanellakisP,Gadowski T, et al. Depletion of B2 but Not B1a B Cells in BAFF Receptor Deficient ApoE-/- Mice Attenuates Atherosclerosis by Potently Ameliorating Arterial Inflammation. PLoSONE. 2012;7((1)):e29371.

Ouyang X, Liu Z. Regulatory T cells and macrophages in atherosclerosis: from mechanisms to clinical significance. Front Immunol. 2024;15:1435021.

Jones GT, Bown MJ, Gretarsdottir S, Romaine SP, Helgadottir A, Yu G, et al. A sequence variant associated with sortilin-1 (SORT1) on 1p13.3 is independently associated with abdominal aortic aneurysm. Hum Mol Genet. 2013;22(14):2941-7.

Zhang L, Xia C, Yang Y, Sun F, Zhang Y, Wang H, et al. DNA methylation and histone post-translational modifications in atherosclerosis and a novel perspective for epigenetic therapy. Cell Commun Signal. 2023;21(1):344.

Dias SVM, Flumignan RLG, Carvas N, Iared W. Accuracy of duplex ultrasound in peripheral artery disease: a systematic review and meta-analysis. J Vasc Bras. 2025;24:e20240033.

Gupta P, Mammarappallil JG, Chiles C, Entrikin DW. CT Angiography of the Aorta and Aortic Diseases. Current Cardiovascular Imaging Reports. 2012;5(5):337-51.

Esposito A, Ravelli S, Papa M, Del Maschio A. Magnetic Resonance Imaging of the Aorta. In: Chiesa R, Melissano G, Zangrillo A, editors. Thoraco-Abdominal Aorta: Surgical and Anesthetic Management. Milano: Springer Milan; 2011. p. 103-14.

Roh JW, Bae S, Johnson TW, Kim Y, Cho DK, Kim JS, et al. Impact of intravascular ultrasound in acute myocardial infarction patients at high ischemic risk. Rev Esp Cardiol (Engl Ed). 2023;76(8):589-99.

Loffroy R, Falvo N, Galland C, Fréchier L, Ledan F, Midulla M, Chevallier O. Intravascular Ultrasound in the Endovascular Treatment of Patients With Peripheral Arterial Disease: Current Role and Future Perspectives. Front Cardiovasc Med. 2020;7:551861.

Antithrombotic Trialists C. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Bmj. 2002;324(7329):71-86.

Belch JJF, Brodmann M, Baumgartner I, Binder CJ, Casula M, Heiss C, et al. Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease: European Atherosclerosis Society/European Society of Vascular Medicine Joint Statement. Atherosclerosis. 2021;338:55-63.

Whelton PK, Carey RM, Aronow WS, Casey DE, Jr., Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269-324.

L R, KI P, M S. - Angioplasty and stenting for peripheral arterial disease of the lower limbs: an. - Cochrane Database Syst Rev 2017 Feb 1;2017(2):CD012542 doi:. (- 1469-493X (Electronic)):T - epublish.

Mazzolai L, Teixido-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M, et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases: Developed by the task force on the management of peripheral arterial and aortic diseases of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), the European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN), and the European Society of Vascular Medicine (ESVM). European Heart Journal. 2024;45(36):3538-700.

Bera A, Sen D. Promise of adeno-associated virus as a gene therapy vector for cardiovascular diseases. Heart Fail Rev. 2017;22(6):795-823.

Zhang H, Zhan Q, Huang B, Wang Y, Wang X. AAV-mediated gene therapy: Advancing cardiovascular disease treatment. Front Cardiovasc Med. 2022;9:952755.

Liu Y, Xu Y, Fang F, Zhang J, Guo L, Weng Z. Therapeutic Efficacy of Stem Cell-based Therapy in Peripheral Arterial Disease: A Meta-Analysis. Plos One. 2015;10(4):e0125032.

Yamawaki-Ogata A, Mutsuga M, Narita Y. A review of current status of cell-based therapies for aortic aneurysms. Inflamm Regen. 2023;43(1):40.